# David J. Kereiakes

> David J. Kereiakes is a venture - series unknown investor at Windham Venture Partners backing Health Care. See 3 investments, check sizes, portfolio. Updated…

- Type: Angel Investor
- Fund: [Windham Venture Partners](https://shizune.co/investors/profile/windham-venture-partners)
- Location: Seattle, United States
- Total investments: 3
- Last investment: Aug 2025
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/david-kereiakes-7b0b5321/

David J. Kereiakes is a venture - series unknown investor at Windham Venture Partners in Seattle focused on Health Care and FinTech. David J. Kereiakes is the Managing Partner of Windham Venture Partners. He previously worked at MidAmerica Healthcare Investors Network as a President and Board Director. David J. Kereiakes attended Kelley School of Business.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 67% |
| FinTech | 1 | 33% |
| Fitness | 1 | 33% |
| Wellness | 1 | 33% |
| Medical Device | 1 | 33% |

8 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Venture - Series Unknown | 2 | 67% |
| Series B | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Israel | 1 | 33% |
| United States | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| PainTEQ | PainTEQ provides solutions and services to the interventional pain management community. |  | Venture - Series Unknown | Aug 27, 2025 |  |
| TailorMed | TailorMed is a health IT company that works with providers, pharmacies and manufacturers to reduce patient financial toxicity and create efficiencies across the patient treatment lifecycle. Our end-to-end platform applies algorithms and automations to make the co-pay assistance and free drug order processes seamless and leverages our deep data setto create actionable insights. | $27.5M | Series B | Nov 21, 2024 |  |
| TailorMed | TailorMed is a health IT company that works with providers, pharmacies and manufacturers to reduce patient financial toxicity and create efficiencies across the patient treatment lifecycle. Our end-to-end platform applies algorithms and automations to make the co-pay assistance and free drug order processes seamless and leverages our deep data setto create actionable insights. | $20M | Venture - Series Unknown | Jun 07, 2021 |  |

3 of 3 investments shown.

## Co-investors
- [Sanara Ventures](https://shizune.co/investors/profile/sanara-ventures) — VC Fund, 2 deals together
- [Triventures](https://shizune.co/investors/profile/triniventures) — VC Fund, 2 deals together
- [Triventures](https://shizune.co/investors/profile/triventures) — VC Fund, 2 deals together
- [UnityPoint Health Ventures](https://shizune.co/investors/profile/unitypoint-health-ventures) — VC Fund, 2 deals together
- [Accelmed](https://shizune.co/investors/profile/accelmed) — VC Fund, 1 deal together
- [Almeda Ventures](https://shizune.co/investors/profile/almeda-ventures) — VC Fund, 1 deal together

## About Windham Venture Partners

VC Fund · New York, United States

Founded in 2006, Windham is a New York City based venture capital firm focused on healthcare, with a particular emphasis on medical technology (devices and diagnostics) and digital health (the intersection of biology, genomics, and information technology). Windham seeks to invest in and partner with companies that are commercializinggame-changing technologies to serve unmet needs in order to improve the lives of large numbers of patients and yield robust returns for its investors. For more information visit: www.windhamvp.com

5 contacts available at Windham Venture Partners.

| Name | Title | Profile |
| --- | --- | --- |
| Adam Fine | Co-Founder, General Partner & CEO | https://shizune.co/investors/profile/adam-fine |
| Lorne Taichman | Director of Science & Technology | https://shizune.co/investors/profile/lorne-taichman-md-phd |
| Roger Fine | Co-Founder & Chairman; Chairman of the Robert Wood Johnson Foundation | https://shizune.co/investors/profile/roger-fine |
| David J. Kereiakes | Managing Partner | https://shizune.co/investors/profile/david-j-kereiakes |
| Joe Proto | Venture Partner | https://shizune.co/investors/profile/joe-proto |

## Similar investors

### Similar stage
- [Bossa Invest](https://shizune.co/investors/profile/bossanova-investimentos) — VC Fund
- [Almi Invest](https://shizune.co/investors/profile/almi-invest) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund

## FAQ

### What does David J. Kereiakes invest in?

David J. Kereiakes invests primarily in Health Care, FinTech and Fitness startups, most often at Venture - Series Unknown and Series B stage. Most of the 3 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did David J. Kereiakes last invest?

The most recent investment recorded for David J. Kereiakes closed in Aug 2025. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co